Navigation Links
Alsius Corporation to Host Fourth Quarter and Year-End 2007 Financial Results Conference Call/Webcast on March 13, 2008
Date:3/6/2008

IRVINE, Calif., March 6 /PRNewswire-FirstCall/ -- Alsius Corporation (Nasdaq: ALUS), the worldwide leader in intravascular patient temperature management therapies, announced it will release its fourth quarter and year-end 2007 financial results on March 13, 2008, following the market close.

A conference call and webcast to review the results will follow the same day at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time). This call will be open to all interested parties live via the conference lines listed below. A live webcast will be available on the Investor Relations section of the company's website http://www.alsius.com at 1:30 p.m. PT (4:30 p.m. ET). Beginning 90 minutes after the conference call concludes, an archived version of the webcast will be available on the site, and a telephone replay of the call will be available via the dial-in numbers listed below.

Date: Thursday, March 13, 2008

Live call: Callers within the U.S. may dial 877-440-5791. International

callers can dial 719-325-4879. No passcode is necessary for the

live call.

Webcast: A webcast will be available live via the Investor Relations

section of the company's website http://www.alsius.com at

1:30 p.m. PT (4:30 p.m. ET). Beginning 90 minutes after the

conference call concludes, an archived version of the webcast

will be available on the site.

Replay: Telephone replay will be available beginning 90 minutes after

the call concludes, from March 13 through March 31, 2008. For

the U.S. and Canada, dial 888-203-1112; conference

identification number 3423016. International callers, dial

719-457-0820; conference identification number 3423016.

About Alsius

Alsius, headquartered in Irvine, CA, is a commercial-stage medical device company that develops, manufactures and sells proprietary products to precisely control patient temperature in hospital critical care settings. Controlling body temperature, through cooling and warming, is becoming the standard of care for patients in select critical conditions and those undergoing a variety of surgical procedures. Alsius markets a comprehensive suite of catheter-based intravascular temperature management products that address the need for effective, accurate, easy-to-use and cost-effective control of body temperature in critical care patients. For more information, visit http://www.alsius.com .


'/>"/>
SOURCE Alsius Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO) With $3.52 Price Target
2. MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on March 4, 2008
3. Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation
4. Insulet Corporation to Report Fourth Quarter and Full Year 2007 Financial Results on Monday, March 17
5. Pharmion Corporation Announces 2007 Operating Results
6. Verenium Corporation to Present at Piper Jaffray Clean Technology & Renewables Conference
7. VLST Corporation Announces Board and Executive Management Appointments
8. AGA Medical Corporation Receives European CE Mark Approval for the AMPLATZER(R) Duct Occluder II
9. AGA Medical Corporation Responds to Occlutech Statement on the Status of the Ongoing Patent Litigation in Europe
10. LifeCell Corporation Revises Full Year 2007 Preliminary Results and Schedules Fourth Quarter 2007 Financial Results Conference Call; February 27, 2008 at 10:00 a.m. Eastern
11. Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... SAN FRANCISCO , February 12, 2016 /PRNewswire/ ... Precision Medicine Efforts by Enabling Scientific Understanding of ... Disorders and Rare Diseases --> ... for genomic diagnostics in South Asia and a leading ... it would contribute $10 million to the GenomeAsia ...
(Date:2/11/2016)... , Germany and ... QGEN ; Frankfurt Prime Standard: QIA) today ... Targeted RNA Panels for gene expression profiling, expanding QIAGEN,s ... (NGS). The panels enable researchers to select from over ... changes and discover interactions between genes, cellular phenotypes and ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... to delivering cutting-edge information focused on the development and manufacture of biopharmaceuticals ... a premier sponsor of the 2016 BioProcess International Awards – Recognizing Excellence ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... more than 150 years, continues today to pursue the highest level of accuracy ... analytical instruments: the AR9 Refractometer and the AR5 Refractometer. Accurate, reliable and ...
Breaking Biology Technology:
(Date:2/9/2016)... Inc. (NASDAQ: AWRE ), a leading supplier of biometrics software ... year ended December 31, 2015.  --> ... $6.9 million, an increase of 61% compared to $4.3 million in ... of 2015 was $2.6 million compared to $0.2 million in the ... --> Higher revenue and operating income in the fourth quarter ...
(Date:2/4/2016)... , Feb. 4, 2016 The field ... one of the most popular hubs of the ... and other huge studies of human microbiota, have ... few years, the microbiome space has literally exploded ... research. This report focuses on biomedical aspects ...
(Date:2/3/2016)... , Feb. 3, 2016 ... addition of the "Emotion Detection and ... Learning, and Others), Software Tools (Facial Expression, ... End Users,and Regions - Global forecast to ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has announced ...
Breaking Biology News(10 mins):